How does COVID-19 affect prostate cancer?

Published Date: 14 Mar 2023

As the COVID-19 pandemic spreads, access to and delivery of health services has been disrupted like never before. How has it affected the treatment of prostate cancer?

Read Full News

Latest News

Game Changers: Navigating Zongertinib’s Role in HER2+ NSCLC

Dr Mark Kris discusses zongertinib in HER2+ NSCLC, detailing its efficacy, dosing, and key tolerability advantages.

Spotting Seborrheic Keratosis vs Melanoma in Primary Care

In primary care settings, recognizing the difference between seborrheic keratosis and melanoma can guide timely biopsy and reduce missed diagnoses.

Beyond Water and Oxalate: New Era in Kidney Stone Prevention

New approaches to kidney stone prevention are combining traditional diet therapy with insights from genetics, metabolomics, and the microbiome.

Lyme Disease 101: Stages, Testing, and Prevention

Not every Lyme case comes with a bullseye rash, and not every case needs a blood test. The Curbsiders clear up the confusion around Lyme's stages, testing, and coinfections.

Excess and Dysfunctional Fat as a Primary Driver of HFpEF

The role of excess and dysfunctional fat in the genesis of HFpEF is well recognized, likely representing a primary or major upstream contributing cause in the large majority of patients.

Primary or Substance-Induced Psychosis? How to Tell and Treat

Distinguishing substance-induced psychosis from primary psychotic disorders starts with the history. Dr Adjoa Smalls-Mantey reviews the diagnostic clues and treatment approach.

Todays Updates

Dual Checkpoint Blockade Boosts Breast Cancer pCR

Patients with high-risk ERBB2-negative breast cancer receive dual checkpoint blockade with cemiplimab and fianlimab in addition to standard neoadjuvant chemotherapy.

Todays Updates

Dual Checkpoint Blockade Boosts Breast Cancer pCR

Patients with high-risk ERBB2-negative breast cancer receive dual checkpoint blockade with cemiplimab and fianlimab in addition to standard neoadjuvant chemotherapy.

Latest News

Dr Mark Kris discusses zongertinib in HER2+ NSCLC, detailing its efficacy, dosing, and key tolerability advantages.

In primary care settings, recognizing the difference between seborrheic keratosis and melanoma can guide timely biopsy and reduce missed diagnoses.

New approaches to kidney stone prevention are combining traditional diet therapy with insights from genetics, metabolomics, and the microbiome.

Not every Lyme case comes with a bullseye rash, and not every case needs a blood test. The Curbsiders clear up the confusion around Lyme's stages, testing, and coinfections.

The role of excess and dysfunctional fat in the genesis of HFpEF is well recognized, likely representing a primary or major upstream contributing cause in the large majority of patients.

Distinguishing substance-induced psychosis from primary psychotic disorders starts with the history. Dr Adjoa Smalls-Mantey reviews the diagnostic clues and treatment approach.

News All Time

A 5-Week-Old Male Presents With Blisters on His Right Leg

Examination revealed pink inflammatory papules and vesicles with areas of brown scale in a linear distribution extending from just above the right medial malleolus to the right inguinal crease.

Fever and Rash Reveal Japanese Spotted Fever in Woman

Recognizing fever, rash, and an eschar after tick exposure can support early diagnosis and timely antibiotic treatment, reducing the risk for severe complications.

Lost in Translation: Cancer Care's Coordination Problem

No shared records. No standard handoff. No common language. Three physicians break down why cancer care coordination keeps failing.

S3 Episode 5: The Future of Endometrial Cancer Pathology

Drs Ursula A. Matulonis and Marisa R. Nucci discuss the future of AI and pathology and how genetics and genomics play a role in the diagnosis of endometrial cancer.

What ASCO 2026 Taught Us About Scaling AI in Cancer Care

The next era of oncology AI won’t be won by the best model, the highest benchmarks, or flashiest press release. It will be won by the most reliable pathway to deployability.

Practice-Changing Data in GI Oncology

From ASCO 2026, Dr Mark Lewis breaks down a 'transformational' shift in GI oncology, from the historic RAS revolution to biomarker-driven advances in colon cancer.

S1 Episode 1: Can Primary Care Catch MASLD Before Cirrhosis?

MASLD is a silent condition and labs may look normal. Drs VanWagner and Shubrook walk through who to screen, how to use FIB-4, and when primary care can manage MASLD without a specialist.

S1 Episode 2: Recurrent UTIs in Older Women

Drs Anne Lenore Ackerman and Melissa Kaufman discuss recurrent UTIs in older women and its association with genitourinary syndrome of menopause.

Herpes Simplex Virus Esophagitis in an Immunocompetent Man

Severe esophageal symptoms that do not respond to standard treatment may warrant endoscopic evaluation and targeted diagnostic testing.

Tailoring Prostate Cancer Care in Men With Limited Longevity

Not every man with prostate cancer benefits from aggressive therapy. Drs Timothy Daskivich and John Leppert explore how to avoid overtreatment in men with limited longevity.

Older Man With Lyme Neuroborreliosis After Tick Bite

Facial palsy, encephalitis, and cerebrospinal fluid abnormalities ultimately indicated Lyme neuroborreliosis, despite early doxycycline treatment.

HLTH Europe 2026

Read clinically focused news coverage of key developments from HLTH Europe 2026

Data Updates Shift Treatment Standards in Gyn-Oncology

At ASCO 2026, Dr Susana Campos reviews pivotal gyn-onc updates, from practice-changing long-term IO survival in endometrial cancer to next-generation ADCs.

UC Care Shifts: What’s Changed in the New ACG Guideline?

In this interview, Dr David Rubin discusses the changes in ulcerative colitis care that led to the ACG clinical guideline update.

Highlights in Prostate Cancer From AUA 2026

Extent of lymph node dissection, defining high-risk criteria, oral androgen deprivation therapy (ADT), and darolutamide plus ADT are among the highlights for prostate cancer management from AUA 2026.

Frozen Testicular Tissue Yields Sperm After 15 Years

A Belgian team has reported sperm production after transplanting testicular tissue frozen for more than 15 years, a potential breakthrough for fertility preservation in boys.

Recommended News For You

Mobile prostate cancer screening clinic can ID the disease in disadvantaged men

Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars

NEET SS Counseling 2023: MCC provides information on DNB SS Medical Oncology seats available at ESIC Medical College and Hospital Faridabad.

It has been discovered that personalized dosing in the treatment of prostate cancer improves patient outcomes.

AACR: American Association for Cancer Research

Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLL

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Recommended Articles For You

AI-Driven Chemotherapy: Transforming Cancer Care with Precision and Efficiency 

Navigating the Evolving Landscape of Oncology Clinical Trials in the Era of Precision Medicine 

The Importance of Having a Quick and Effective Heparin Antidote  

Understanding Epoetin and Its Role in Treating Chronic Kidney Disease  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Kekoa Taparra, a native Hawaiian physician-scientist, is becoming well-known.

2.

GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer

3.

AI innovation unlocks non-surgical way to detect brain cancer spread

4.

When in Breast Cancer Treatment Are CDK4/6 Inhibitors Best?

5.

Long-term study links chronic conditions in midlife to higher cancer risk and mortality

1.

Cancer Immunotherapy: Advances, Guidelines, and Practical Tools for Modern Oncology Practice

2.

Symptoms and Causes of Phlegmasia Cerulea Dolens: A Comprehensive Guide 

3.

Blastic Plasmacytoid Dendritic Cell Neoplasm and the Dawn of AI-powered Diagnostics

4.

From Autoimmune Disorders to COVID-19: How Plasmapheresis Is Revolutionizing Modern Medicine 

5.

The Ultimate Guide to Understanding Abiraterone and its Uses in Cancer Treatment 

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

1.

Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II

2.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

3.

Current Scenario of Cancer- Palliative Care to Close the Care Gap

4.

Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.

5.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot